Dimed S.A. Distribuidora de Medicamentos

BOVESPA:PNVL3 Stock Report

Market Cap: R$1.4b

Dimed Distribuidora de Medicamentos Future Growth

Future criteria checks 4/6

Dimed Distribuidora de Medicamentos is forecast to grow earnings and revenue by 23.4% and 10.8% per annum respectively. EPS is expected to grow by 27% per annum. Return on equity is forecast to be 13.6% in 3 years.

Key information

23.4%

Earnings growth rate

27.0%

EPS growth rate

Consumer Retailing earnings growth29.9%
Revenue growth rate10.8%
Future return on equity13.6%
Analyst coverage

Low

Last updated14 Nov 2024

Recent future growth updates

Dimed S.A. Distribuidora de Medicamentos Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Nov 17
Dimed S.A. Distribuidora de Medicamentos Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Recent updates

Dimed S.A. Distribuidora de Medicamentos Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Nov 17
Dimed S.A. Distribuidora de Medicamentos Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Investors Could Be Concerned With Dimed Distribuidora de Medicamentos' (BVMF:PNVL3) Returns On Capital

Nov 04
Investors Could Be Concerned With Dimed Distribuidora de Medicamentos' (BVMF:PNVL3) Returns On Capital

These 4 Measures Indicate That Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Is Using Debt Extensively

Jul 12
These 4 Measures Indicate That Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Is Using Debt Extensively

Investors Shouldn't Be Too Comfortable With Dimed Distribuidora de Medicamentos' (BVMF:PNVL3) Robust Earnings

May 27
Investors Shouldn't Be Too Comfortable With Dimed Distribuidora de Medicamentos' (BVMF:PNVL3) Robust Earnings

Be Wary Of Dimed Distribuidora de Medicamentos (BVMF:PNVL3) And Its Returns On Capital

Apr 15
Be Wary Of Dimed Distribuidora de Medicamentos (BVMF:PNVL3) And Its Returns On Capital

Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Seems To Use Debt Quite Sensibly

Mar 25
Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Seems To Use Debt Quite Sensibly

The Returns On Capital At Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Don't Inspire Confidence

Jan 06
The Returns On Capital At Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Don't Inspire Confidence

Dimed S.A. Distribuidora de Medicamentos' (BVMF:PNVL3) Stock Retreats 26% But Earnings Haven't Escaped The Attention Of Investors

Oct 23
Dimed S.A. Distribuidora de Medicamentos' (BVMF:PNVL3) Stock Retreats 26% But Earnings Haven't Escaped The Attention Of Investors

Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Is Reinvesting At Lower Rates Of Return

Aug 15
Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Is Reinvesting At Lower Rates Of Return

Earnings and Revenue Growth Forecasts

BOVESPA:PNVL3 - Analysts future estimates and past financials data (BRL Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20266,391187193145
12/31/20255,702145-332725
12/31/20245,15112263222
9/30/20244,818104125274N/A
6/30/20244,71291190321N/A
3/31/20244,660108178313N/A
12/31/20234,46193157297N/A
9/30/20234,32588144282N/A
6/30/20234,21183175325N/A
3/31/20234,1168469228N/A
12/31/20223,9908624205N/A
9/30/20223,7998517198N/A
6/30/20223,5848321189N/A
3/31/20223,3758015175N/A
12/31/20213,22579-4131N/A
9/30/20213,13579-5678N/A
6/30/20213,03279-5863N/A
3/31/20212,87862-4157N/A
12/31/20202,8195646131N/A
9/30/20202,7645682147N/A
6/30/20202,754623490N/A
3/31/20202,7807873133N/A
12/31/20192,7257775129N/A
9/30/20192,6388089131N/A
6/30/20192,5627965106N/A
3/31/20192,5007672117N/A
12/31/20182,4327551110N/A
9/30/20182,35965-2045N/A
6/30/20182,31759N/A62N/A
3/31/20182,28259N/A29N/A
12/31/20172,25860N/A41N/A
9/30/20172,23860N/A78N/A
6/30/20172,19159N/A68N/A
3/31/20172,14657N/A104N/A
12/31/20162,12953N/A102N/A
9/30/20162,09553N/A92N/A
6/30/20162,07450N/A93N/A
3/31/20162,04350N/A76N/A
12/31/20151,98645N/A73N/A
9/30/20151,96344N/A59N/A
6/30/20151,92743N/A56N/A
3/31/20151,91648N/A26N/A
12/31/20141,88749N/A23N/A
9/30/20141,83550N/A29N/A
6/30/20141,82358N/A50N/A
3/31/20141,78655N/A66N/A
12/31/20131,74056N/A62N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: PNVL3's forecast earnings growth (23.4% per year) is above the savings rate (10.4%).

Earnings vs Market: PNVL3's earnings (23.4% per year) are forecast to grow faster than the BR market (12.5% per year).

High Growth Earnings: PNVL3's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: PNVL3's revenue (10.8% per year) is forecast to grow faster than the BR market (7.5% per year).

High Growth Revenue: PNVL3's revenue (10.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: PNVL3's Return on Equity is forecast to be low in 3 years time (13.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y